Amyris, Inc. (AMRS): Price and Financial Metrics
GET POWR RATINGS... FREE!
AMRS POWR Grades
- Growth is the dimension where AMRS ranks best; there it ranks ahead of 74.14% of US stocks.
- The strongest trend for AMRS is in Growth, which has been heading up over the past 31 weeks.
- AMRS ranks lowest in Stability; there it ranks in the 3rd percentile.
AMRS Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for AMRS is -1 -- better than only 4.62% of US stocks.
- AMRS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 5.06% of US stocks.
- In terms of volatility of its share price, AMRS is more volatile than 97.64% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Amyris Inc, a group of peers worth examining would be OMER, PRTK, TXMD, AQST, and QMCO.
- AMRS's SEC filings can be seen here. And to visit Amyris Inc's official web site, go to www.amyris.com.
AMRS Valuation Summary
- In comparison to the median Basic Materials stock, AMRS's price/earnings ratio is 130.74% lower, now standing at -7.9.
- Over the past 130 months, AMRS's price/sales ratio has gone up $4.6.
- Over the past 130 months, AMRS's price/sales ratio has gone up $4.6.
Below are key valuation metrics over time for AMRS.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| AMRS | 2020-05-05 | 2.6 | -1.5 | -1.5 | -3.7 |
| AMRS | 2017-11-28 | 1.9 | -0.8 | -1.1 | -3.9 |
| AMRS | 2016-01-22 | 7.3 | -1.9 | -2.2 | -10.7 |
| AMRS | 2014-01-27 | 10.5 | 327.0 | -2.4 | -3.3 |
| AMRS | 2013-01-03 | 1.8 | 2.6 | -0.9 | -1.2 |
| AMRS | 2012-04-23 | 1.2 | 1.1 | -1.0 | -0.7 |
AMRS Price Target
For more insight on analysts targets of AMRS, see our AMRS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $23.67 | Average Broker Recommendation | 1.33 (Strong Buy) |
AMRS Stock Price Chart Interactive Chart >
AMRS Price/Volume Stats
| Current price | $15.66 | 52-week high | $23.42 |
| Prev. close | $15.85 | 52-week low | $1.88 |
| Day low | $15.61 | Volume | 2,154,300 |
| Day high | $16.21 | Avg. volume | 4,508,003 |
| 50-day MA | $14.51 | Dividend yield | N/A |
| 200-day MA | $9.53 | Market Cap | 4.62B |
Amyris, Inc. (AMRS) Company Bio
Amyris, Inc. provides various alternatives to a range of petroleum-sourced products for the consumer care, specialty chemical, and transportation fuel markets worldwide. The company was founded in 2003 and is based in Emeryville, California.
Latest AMRS News From Around the Web
Below are the latest news stories about Amyris Inc that investors may wish to consider to help them evaluate AMRS as an investment opportunity.
Amyris to Present at the Virtual Morgan Stanley 6th Annual Sustainable Futures Conference on June 9, 2021Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that John Melo, Director, President and Chief Executive Officer, will participate in a virtual fireside chat at the Morgan Stanley 6th Annual Sustainable Futures Conference on Wednesday, June 9th at 3:30 pm ET. |
Why Amyris, Gevo, and Aemetis Stocks Popped WednesdayOne of these things is (no longer) like the others. |
Amyris CEO on the company's Q1 earnings reportJohn Melo, Amyris CEO, joined Yahoo Finance Live to discuss the company's first-quarter earnings report and why the company is teaming up with Ingredion. |
Amyris to Present at the Virtual Morgan Stanley Global Consumer Ingredients Day on May 18, 2021Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that management will participate in a fireside chat at the virtual Morgan Stanley Global Consumer Ingredients Day on Tuesday, May 18th at 10:45 am ET. |
Amyris Brand Pipette™ Partners With Baby2baby To Help Babies And Families In NeedAmyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that Pipette™, its clean baby and mothers skincare brand, will partner with non-profit organization, Baby2Baby to donate 200,000 units of its award-winning hand sanitizer to families living in poverty nationwide. |
AMRS Price Returns
| 1-mo | 34.19% |
| 3-mo | -26.79% |
| 6-mo | 283.82% |
| 1-year | 304.65% |
| 3-year | 188.40% |
| 5-year | 108.80% |
| YTD | 153.60% |
| 2020 | 99.84% |
| 2019 | -7.49% |
| 2018 | -10.93% |
| 2017 | -65.75% |
| 2016 | -54.94% |
Continue Researching AMRS
Want to see what other sources are saying about Amyris Inc's financials and stock price? Try the links below:Amyris Inc (AMRS) Stock Price | Nasdaq
Amyris Inc (AMRS) Stock Quote, History and News - Yahoo Finance
Amyris Inc (AMRS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...